Breast cancer is classified into three primary categories: estrogen receptor–positive (ER+) breast cancer, human epidermal growth factor receptor 2-positive (HER2+) breast cancer, and triple-negative breast cancer (TNBC) (Gradishar et al., 2024). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.